Unlocking the potential of cannabis
The foremost source of independent data, intelligence and strategy for the cannabis industry.
International Cannabis Weekly: Issue 141 out now
COVID-19: The turning point for global cannabis legalisation
International Cannabis Weekly: Issue 140 out now
The Cannabis World Map
Click each continent to view key statistics on healthcare, market size and more
Europe
Latin America
North America
Oceania
Africa
Asia
About Us
Learn More
Prohibition Partners unlocks the potential of cannabis through data, intelligence and strategy.
We enable our clients to make better business decisions that deliver tangible progress and transformational growth while disrupting mainstream verticals.
We work with the industry’s most influential stakeholders, some of the world’s best known brands and an unrivalled network of analysts, innovators and advisors.
Our Services
Find out moreData /
Bespoke Research | Polling | Consumer Insights | Market Forecasting
Intelligence /
Market Analysis | Regulatory Guidance | Supply & Demand | Networking
Strategy /
Market Entry | M&A Advisory | Strategic Partnerships | Business Development | Licensing
UNLOCKING THE POTENTIAL OF CANNABIS
Prohibition Partners LIVE will be the largest cannabis event in the world this summer. We are taking our industry-leading conferences online, delivering you agenda-setting content, targeted virtual networking and engaging digital experiences. All at the touch of a button.
Click here to find out more.
News + Insights
View All03.04.2020
As of Friday, 3 April 2020, there are over one million confirmed cases of coronavirus worldwide. Analysts from the IMF and UN are predicting a global recession will follow in...
COVID-19: The turning point for global cannabis legalisation
27.03.2020
As of 27 March, we have seen over 530,000 confirmed cases of coronavirus (COVID-19) across 199 countries. As the outbreak develops, Prohibition Partners is monitoring the situation and reporting on...
INSIGHT: How COVID-19 Is Impacting The Cannabis Industry
International Cannabis
Weekly
View All
03.04.2020
Issue
141
The latest updates on how the Coronavirus is impacting the cannabis industry around the world...
27.03.2020
Issue
140
The latest updates on how the Coronavirus is impacting the cannabis industry around the world...
20.03.2020
Issue
139
Discover how the coronavirus is impacting cannabis consumer behaviour and the rest of the international...
13.03.2020
Issue
138
Prohibition Partners releases PSYCH: The Psychedelics as Medicine Report while The US FDA reopens their...
Press
View PageProhibition Partners Releases PSYCH: The Psychedelics as Medicine Report
Prohibition Partners Launches the European Cannabis Report: 5th Edition
For press inquiries, please contact us at media@prohibitionpartners.com.
What we're saying
🌎COVID-19: The turning point for global cannabis legalisation
🇳🇿New Zealand opens applications for new medical cannabis programme
🇺🇸New York State drops recreational cannabis legalisation in annual budget
All this and more in ICW issue 141:
https://prohibitionpartners.com/2020/04/03/141-2/
Prohibition Partners Insights & Reports Director, Alexandra Curley, has shared her thoughts and research on the ongoing COVID-19 outbreak and its impact on the cannabis industry in this podcast from The Hoban Minute. Listen to the full episode now:
https://thehobanminute.podbean.com/e/the-hoban-minute-17-prohibition-partners-alexandra-curley-how-covid-19-may-impact-consumer-behavior/
Ex-government advisor to the British government, David Nutt, has said that rules restricting research into psychedelic medicines should be relaxed, as trials recently completed have shown promising results in treating mental health disorders.
https://www.theguardian.com/politics/2020/apr/02/ease-rules-on-use-of-psychedelic-drugs-in-research-urges-david-nutt